Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T01:10:31.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    9%
    Check dated 2025-10-05T09:57:14.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0.
    Difference
    0.2%
    Check dated 2025-09-28T03:09:59.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Updated the page to include current date 2025-09-16 and a new 2025-09-12 Study Status; removed an older date 2025-06-10. No major changes to core content or pricing are implied.
    Difference
    0.9%
    Check dated 2025-09-20T22:06:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, signaling a minor patch; the Back to Top link has been removed. No other substantive changes to core content, pricing, stock, or time-related information were introduced.
    Difference
    0.5%
    Check dated 2025-09-13T17:36:16.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.5%
    Check dated 2025-09-06T14:49:11.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.